The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Caspase activation precedes and leads to tangles
Open accessAbstract
Studies of post-mortem tissue have shown that the location of fibrillar tau deposits, called neurofibrillary tangles (NFT), matches closely with regions of massive neuronal death, severe cytological abnormalities, and markers of caspase activation and apoptosis, leading to the idea that tangles cause neurodegeneration in Alzheimer's disease and tau-related frontotemporal dementia. However, using in vivo multiphoton imaging to observe tangles and activation of executioner caspases in living tau transgenic mice (Tg4510 strain), we find the opposite: caspase activation occurs first, and precedes tangle formation by hours to days. New tangles form within a day. After a new tangle forms, the neuron remains alive and caspase activity seems to be suppressed. Similarly, introduction of wild-type 4-repeat tau (tau-4R) into wild-type animals triggered caspase activation, tau truncation and tau aggregation. Adeno-associated virus-mediated expression of a construct mimicking caspase-cleaved tau into wild-type mice led to the appearance of intracellular aggregates, tangle-related conformational- and phospho-epitopes, and the recruitment of full-length endogenous tau to the aggregates. On the basis of these data, we propose a new model in which caspase activation cleaves tau to initiate tangle formation, then truncated tau recruits normal tau to misfold and form tangles. Because tangle-bearing neurons are long-lived, we suggest that tangles are 'off pathway' to acute neuronal death. Soluble tau species, rather than fibrillar tau, may be the critical toxic moiety underlying neurodegeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent evidence suggests that executioner caspases 3 and 7 may contribute to tau, the protein responsible for forming NFTs, pathology by cleaving tau after Asp421 to yield a cytotoxic Δtau fragment (Rissman et al., 2004; Rohn et al., 2008; de Calignon et al., 2010).”
From The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease (2011) · cites this paper as de Calignon et al., 2010
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“may contribute to cognitive decline”
From The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease (2011) · cites this paper as de Calignon et al., 2010
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“the early cleavage of tau by these caspases initiates tau aggregation and phosphorylation”
From The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease (2011) · cites this paper as de Calignon et al., 2010
In the citing paper
“Mitochondrial abnormalities, synaptic loss and dysfunction, altered axonal transport, and activation of cell death pathways (including caspase activation and inflammatory responses) have all been directly or indirectly implicated as consequences of tau mislocalization or oligomerization (20, 40, 43–52).”
From All the Tau We Cannot See (2023) · cites this paper as [43]
In the citing paper
“For example, through direct visualization of the cortex of Tg4510 P301L mice by multiphoton microscopy, Hyman and colleagues were able to determine that caspase activation, and neuronal death, appeared in many instances to precede tangle formation.”
From All the Tau We Cannot See (2023) · cites this paper as [43]
In the citing paper
“Indeed, tangles forming did not lead to neuronal death over the course of the several-month imaging period (43, 51).”
From All the Tau We Cannot See (2023) · cites this paper as [43]
In the citing paper
“Recent data suggest that intracellular protein aggregates of tau have the capacity to seed aggregation of native tau proteins and might propagate their misfolded state in a prion-like manner.”
From Propagation of Tau Pathology in a Model of Early Alzheimer's Disease (2012) · cites this paper as de Calignon et al., 2010
In the citing paper
“The current clinical trial literature is compatible with the idea that AβP-related substances kindle a self-propagating process related to neocortical NFTs, as has been hypothesized (266-269).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [266]
In the citing paper
“whereas tau tangles alone are not sufficient to cause neuronal death”
From Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models (2019) · cites this paper as de Calignon et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943
Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function
SantaCruz, K., Lewis, J., Spires, T., Paulson, J., Kotilinek, L., Ingelsson, M., Guimaraes, A., DeTure, M., Ramsden, M., McGowan, E., et al. (2005) · Science · doi:10.1126/science.1113694 · Cited by 2,014
Self-citationControl of memory formation through regulated expression of a CaMKII transgene
Mayford, M., Bach, M. E., Huang, Y.-Y., Wang, L., Hawkins, R. D., & Kandel, E. R. (1996) · Science · doi:10.1126/science.274.5293.1678 · Cited by 1,550
Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
Gómez‐Isla, T., Hollister, R., West, H., Mui, S., Growdon, J. H., Petersen, R. C., Parisi, J. E., & Hyman, B. T. (1997) · Annals of Neurology · doi:10.1002/ana.410410106 · Cited by 1,489
Self-citationAugustinack, J. C., Schneider, A., Mandelkow, E.-M., & Hyman, B. T. (2002) · Acta Neuropathologica · doi:10.1007/s004010100423 · Cited by 998
Self-citationCaspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease
Gamblin, T. C., Chen, F., Zambrano, A., Abraha, A., Lagalwar, S., Guillozet, A. L., Lu, M., Fu, Y., Garcia-Sierra, F., LaPointe, N., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1630428100 · Cited by 831
Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms
Andorfer, C., Kress, Y., Espinoza, M., De Silva, R., Tucker, K. L., Barde, Y., Duff, K., & Davies, P. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01879.x · Cited by 722
Ramsden, M., Kotilinek, L., Forster, C., Paulson, J., McGowan, E., SantaCruz, K., Guimaraes, A., Yue, M., Lewis, J., Carlson, G., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3279-05.2005 · Cited by 702
Self-citationTau fragmentation, aggregation and clearance: the dual role of lysosomal processing
Wang, Y., Martinez-Vicente, M., Krüger, U., Kaushik, S., Wong, E., Mandelkow, E.-M., Cuervo, A. M., & Mandelkow, E. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp367 · Cited by 617
Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology
Rissman, R. A., Poon, W. W., Blurton-Jones, M., Oddo, S., Torp, R., Vitek, M. P., LaFerla, F. M., Rohn, T. T., & Cotman, C. W. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420640 · Cited by 543
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 525
Other Proteins Involved in Parkinson's Disease and Related Disorders
Cardona, F., & Pérez‐Tur, J. (2016) · Current Protein and Peptide Science · doi:10.2174/1389203717666160311122152 · Cited by 8
Martín‐Ávila, A., Modak, S., Rajamohamedsait, H. B., Dodge, A., Shamir, D. B., Krishnaswamy, S., Sandusky‐Beltran, L. A., Walker, M., Lin, Y., Congdon, E. E., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116291 · Cited by 7
Syk inhibitors reduce tau protein phosphorylation and oligomerization
Yamaguchi, T., Hamano, T., Sada, K., Asano, R., Kanaan, N. M., Sasaki, H., Yen, S.-H. C., Kitazaki, Y., Endo, Y., Enomoto, S., et al. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106656 · Cited by 7
Zhang, S., Saathoff, J. M., & Liu, H. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-101011-2.00008-8 · Cited by 8
Theofilas, P., Wang, C., Butler, D., Morales, D. O., Petersen, C., Ambrose, A. J., Chin, B., Yang, T. T. C., Khan, S., Ng, R. A., et al. (2021) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2024.103954 · Cited by 6
Olesen, M. A., Villavicencio-Tejo, F., Johnson, G. V. W., Porter, G. A., & Quintanilla, R. A. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.02.035 · Cited by 6
Lelos, M. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818084-6.00002-7 · Cited by 5
Hamano, T., & Endo, Y. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89906-2.00006-x · Cited by 7
Dual truncation of tau by caspase-2 accelerates its CHIP-mediated degradation
Reinhardt, L., Musacchio, F., Bichmann, M., Behrendt, A., Ercan-Herbst, E., Stein, J., Becher, I., Haberkant, P., Mader, J. K., Schöndorf, D. C., et al. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106126 · Cited by 6
Graham, R. K., Deng, Y. L., Pouladi, M. A., Vaid, K., Ehrnhoefer, D. E., Southwell, A. L., Bissada, N., Franciosi, S., & Hayden, M. R. (2012) · Journal of Huntington s Disease · doi:10.3233/jhd-120038 · Cited by 6
de Calignon, A., Spires‐Jones, T. L., & Hyman, B. T. (2010) · médecine/sciences · doi:10.1051/medsci/20102610787 · Cited by 6
Self-citationTheofilas, P., Ambrose, A. J., Butler, D., Wang, C., Morales, D. O., Petersen, C., Chin, B., Yang, T. T. C., Khan, S., Ng, R. A., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.051471 · Cited by 6
Takuwa, H., Orihara, A., Takado, Y., Urushihata, T., Shimojo, M., Ishikawa, A., Takahashi, M., Barron, A. M., Ono, M., Maeda, J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.04.368977 · Cited by 6
Baghel, M. S., Burns, G. D., Tsapatsis, M., Mallika, A. P., Cruz, A. L., Cao, T., Chen, X. K., Rosa, I. D. L., Marx, S. R., Ye, Y., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.26.600814 · Cited by 6
Villavicencio-Tejo, F., Olesen, M. A., Ampuero, E., & Quintanilla, R. A. (2025) · Neurochemistry International · doi:10.1016/j.neuint.2025.105991 · Cited by 7
Nerve‐racking – apoptotic and non‐apoptotic roles of caspases in the nervous system of Drosophila
Melzer, J., & Broemer, M. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13213 · Cited by 5
Next generation tau models in Alzheimer's disease research – virus based gene delivery systems
Cubinkova, V., Valachova, B., Brezováková, V., SZABÓ, R., Zimova, I., Kostecká, Z., & Jadhav, S. (2017) · Acta Virologica · doi:10.4149/av_2017_01_13 · Cited by 6
Potential role of Drug Repositioning Strategy (DRS) for management of tauopathy
Zaki, M. O., Elsherbiny, D. A., Salama, M., & Azab, S. S. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120267 · Cited by 6
Genetics of Frontotemporal Dementia
Heetveld, S., Rizzu, P., & Heutink, P. (2015) · Springer eBooks · doi:10.1007/978-3-319-17223-1_5 · Cited by 5
LIU, G., Liu, C., & NING-ZHANG, X. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3803 · Cited by 5
Targeted tau protein degradation: a promising therapeutic approach for tauopathies
Baazaoui, N., Alfaifi, M. Y., Shati, A. A., Saad, R. B., & Garzoli, S. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.11.041 · Cited by 5
Paradise, V., Konrad, K. D., Nguyen, C., Sharif, N. A., Wang, X., Mukim, R. D., Sabu, M., Corjuc, B. T., Bafia, J., Fu, J. M., et al. (2026) · Nature Neuroscience · doi:10.1038/s41593-026-02297-x · Cited by 4
Self-citationFTLD-MAPT mutations and short 5′UTR Tau mRNAs increase Tau translation
da Costa, P. J., Perret, A., Buée, L., Hamdane, M., & Martin, F. (2024) · NAR Molecular Medicine · doi:10.1093/narmme/ugae023 · Cited by 4
Neuronal Models for Studying Tau Pathology
Koechling, T., Lim, F., Hernández, F., & Ávila, J. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2010/528474 · Cited by 6
Dickerson, B. C. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781316091586.016 · Cited by 4
Chi, H., Sang, T., & Chang, H.-Y. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.73198 · Cited by 5
Unconventional secretion of tau by VAMP8 impacts its intra- and extracellular cleavage
Pilliod, J., Gélinas-Faucher, M., & Leclerc, N. M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.912118 · Cited by 4
Kim, J. M., Kim, S., & Lee, Y. (2015) · Neuroreport · doi:10.1097/wnr.0000000000000423 · Cited by 4
Molecular Pathways in Alzheimer’s Disease and Cognitive Function
Chen, X., Reichert, M. C., & Gan, L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802851-3.00005-x · Cited by 3
Controlled Tau Cleavage in Cells Reveals Abnormal Localizations of Tau Fragments
Fourest‐Lieuvin, A., Vinit, A., Blot, B., Perrot, A., Denarier, É., Saudou, F., & Arnal, I. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.08.016 · Cited by 3
In Vivo Imaging of Tau Aggregates in the Mouse Retina
Schön, C., & Herms, J. W. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6598-4_24 · Cited by 3
Tau Pathology in Neurodegenerative Diseases
Vogels, T., & Hromádka, T. (2021) · Neuromethods · doi:10.1007/978-1-0716-1712-0_4 · Cited by 2
Axelsen, T. M., Bager, C. L., Bihlet, A. R., Karsdal, M. A., Henriksen, K., & Tang, M. E. (2023) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2023.36 · Cited by 3
Méduri, G., Guillemeau, K., Daguinot, C., Dounane, O., Genet, M., Ferrara, L., Chambraud, B., Baulieu, E. E., & Giustiniani, J. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230127 · Cited by 3
Liu, W.-F., & Liu, C. (2015) · Chinese Medical Sciences Journal · doi:10.1016/s1001-9294(15)30020-1 · Cited by 3
Chen, S., Chang, Y., Li, L., Acosta, D. M., Morrison, C. T., Wang, C., Julian, D. L., Hester, M. E., Serrano, G. E., Beach, T. G., et al. (2021) · SSRN Electronic Journal · doi:10.21203/rs.3.rs-855234/v1 · Cited by 3
Chronic Pain and Cognitive Dysfunction: Clinical Implement, Mechanism, and Therapeutic Strategy
Hu, J., Gao, P.-Y., Di, R., Chen, O., & Tang, Y. (2026) · Journal of Neuroscience · doi:10.1523/jneurosci.1251-25.2026 · Cited by 3
Clinical and laboratory correlation in patients with consequences of traumatic brain injury
Салій, З. В. (2015) · ScienceRise · doi:10.15587/2313-8416.2015.48249 · Cited by 2
Regulated intramembrane proteolysis, innate immunity and therapeutic targets in Alzheimer’s disease
Hurst, T. P., Coleman-Vaughan, C., Patwal, I., & McCarthy, J. V. (2016) · AIMS molecular science · doi:10.3934/molsci.2016.2.138 · Cited by 2
Neurochemical Aspects of Alzheimer Disease
Farooqui, A. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-15889-1_1 · Cited by 2
Mueller, R. L., Combs, B., & Kanaan, N. M. (2025) · Scientific Reports · doi:10.1038/s41598-025-21920-8 · Cited by 2
Duyckaerts, C. J. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107588660.007 · Cited by 2
O’Leary, J. C., Koren, J., & Dickey, C. A. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9540-4 · Cited by 2
Caspases: Regulatory Mechanisms and Their Implications in Pathogenesis and Therapeutics
Parui, A. L., & Bose, K. (2017) · Springer eBooks · doi:10.1007/978-981-10-6141-7_18 · Cited by 2
Role of caspases, apoptosis and additional factors in pathology of Alzheimer's disease
Gupta, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820122-0.00001-7 · Cited by 2
Smith, G. S. T., Voyer-Grant, J. A. M., & Harauz, G. (2012) · Journal of Visualized Experiments · doi:10.3791/3422-v · Cited by 2
Mitochondria in Alzheimer disease : regulatory mechanisms and cell death
Hedskog, L. (2012) · Figshare · Cited by 2
Selective Disposal of Insoluble Protein Aggregates
Seneci, P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800186-8.00005-5 · Cited by 1
Enzymatic Targets for Drug Discovery Against Alzheimer's Disease
ÖZGEN, A. O., & Eyüpoğlu, O. E. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815136142123010009 · Cited by 1
Meng, X., Wang, M., Yang, M., Wang, G., Zhao, Z., Xie, Z., Li, B., Qian, Z., Kang, S. S., Zheng, W., et al. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00718 · Cited by 2
Cheng, W., Yang, S., Lu, Y., Wang, Y., & Tan, A.-H. (2026) · Scientific Reports · doi:10.1038/s41598-026-47003-w · Cited by 1
Guedjdal, S., Leghay, C., Derisbourg, M. J., Eddarkaoui, S., Lecerf, S., Vermon, F., Caillierez, R., Bégard, S., Regost, C., Laloux, C., et al. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00550-8 · Cited by 2
Peripheral biomarkers of neuroinflammation in Alzheimer’s disease and vascular dementia
Ouyang, X., Chia, R. S. L., Chai, Y. L., Chong, Sim, M. A., Jo, D., Arumugam, T. V., Sethi, G., Dawe, G. S., Chen, C. P., et al. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118077 · Cited by 1
Pathogenesis of neurodegenerative diseases via templated recruitment
Guo, J. (2013) · ScholarlyCommons (University of Pennsylvania) · Cited by 1
From Protein Tangles to Genetic Variants: The Central Role of Tau in Neurodegenerative Disease
Julia, H., & Wade‐Martins, R. (2011) · InTech eBooks · doi:10.5772/29839 · Cited by 1
Die dynamische Struktur von Tau‐Filamenten
Bibow, S., Mukrasch, M. D., Chinnathambi, S., Biernat, J., Griesinger, C., Mandelkow�, E., & Zweckstetter, M. (2011) · Angewandte Chemie · doi:10.1002/ange.201105493 · Cited by 1
Tau Phosphorylation as a Therapeutic Target in Alzheimer’s Disease
Medina, M., & Ávila, J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00012-5 · Cited by 1
Stephens, G. S., You, J. C., Fu, C.-H., & Chin, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.21126-7 · Cited by 1
In Vivo-Near Infrared Imaging of Neurodegeneration
Lawson, V., Tumpach, C., Haigh, C. L., & Drew, S. C. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7244-9_17 · Cited by 1
Anastasis: Cell Survival Mechanism
Olagunju, A. S., Olorunfemi, F. G., Teibo, J. O., & Adewolu, A. M. (2020) · Cancer Studies and Molecular Medicine - Open Journal · doi:10.17140/csmmoj-6-131 · Cited by 1
Lee, K. M., Kim, S., Tian, Y., Jung, S. M., Chang, Y., Rhee, H. Y., Park, S., Ryu, C., Lee, W.-I., Kim, E. J., et al. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1388654 · Cited by 1
Soluble 4R0N Tau Abrogates Endocytic Vesicular Dynamics
Mahendran, T. S., Suresh, S., Garimella, L., & Manjithaya, R. R. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.537712 · Cited by 1
Shorter, J. (2011) · Wiley eBooks · doi:10.1002/9781118063903.ch7 · Cited by 1
Entrada de calcio inducida por los oligómeros del péptido amiloide en la Enfermedad de Alzheimer
Ortega, E. C. (2013) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/3786 · Cited by 1
Villamil-Ortiz, J. G. (2019) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.99684546 · Cited by 1
Integrated Bioinformatics Analysis Identifies Pyroptosis-related Genes in Alzheimer’s DiseasePreprint
Guo, T., & Wang, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-1310823/v1 · Cited by 1
Nadel, C. M., Wucherer, K., Oehler, A., Thwin, A. C., Basu, K., Callahan, M. D., Southworth, D. R., Mordes, D. A., Craik, C. S., & Gestwicki, J. E. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.16.553575 · Cited by 1
Helmreich, D. L. (2026) · European Journal of Neuroscience · doi:10.1111/ejn.70498 · Cited by 1
The Microtubule-Dissociating Tau in Neurological Disorders
Jos, F., Schraen‐Maschke, S., & Buée, L. (2012) · InTech eBooks · doi:10.5772/30190
In Vivo Evidence of the Convergence of Type 2 Diabetes and Alzheimer Disease
Park, S. A. (2013) · Wiley eBooks · doi:10.1002/9781118395318.ch24
Other Mechanisms of Neurodegeneration
Boziki, M. K., Papaliagkas, V., & Tsolaki, M. (2011) · Wiley eBooks · doi:10.1002/9781444344110.ch9
Age-associated increases in FKBP51 facilitate tau neurotoxicity
Blair, L. J. (2014) · Digital Commons - University of South Florida (University of South Florida)
Molecular changes during the development of Alzheimer's disease
Wirz, K. T. S. (2013) · Data Archiving and Networked Services (DANS)
Mouse and stem cell models of frontotemporal dementia
Orr, M. E. (2012) · Montana State University ScholarWorks (Montana State University)
Chaves, R. D. S. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2016.tde-05012016-154631
Gan, K. J. (2014) · Summit (Simon Fraser University)
PATHOGENIC ROLE OF MICROGLIA-DERIVED MICROVESICLES IN NEURODEGENERATION
Joshi, P. (2014) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/joshi-pooja_phd2014-01-16
Price, D. L., Savonenko, A. V., Li, T., & Wong, P. C. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511980053.009
Pathophysiologyand animal models of frontotemporal dementia
Warmus, B. A., & Roberson, E. D. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781316091586.018
Active and Passive Immunotherapy Against Tau: Effects and Potential Mechanisms
Yanamandra, K., Diamond, M. I., & Holtzman, D. M. (2016) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-3560-4_9
Ren, Y., Sahara, N., Giasson, B. I., & Lewis, J. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405195-9.00055-x · Cited by 4
Structural Polymorphism in Tau Filaments: An Implication for Neurodegenerative Diseases
Siddiqua, A. (2012) · Digital Commons - DU (University of Denver)
Inhibition of Alzheimer’s type toxic aggregates of tau with fungal secondary metabolites
Paranjape, S. R. (2015) · KU ScholarWorks (University of Kansas)
Kiprowska, M. (2016) · CUNY Academic Works (City University of New York)
Rudinskiy, N., & Spires‐Jones, T. L. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394431-3.00009-2
Self-citationAssembly and Disassembly of Protein Aggregates
Seneci, P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800186-8.00006-7
New Approaches in Glial Biology
Nikić, I., Misgeld, T., & Kerschensteiner, M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-397265-1.00093-9
Review Article Tau: From research to clinical development
Holtzman, D. M., Carrillo, M. C., Hendrix, J. A., Bain, L. J., Catafau, A. M., Gault, L. M., Goedert, M., Mandelkow�, E., Mandelkow, E., Miller, D. S., et al. (2016)
Development and characterization of cell models of tau aggregation
Cavallini, A. (2018) · UCL Discovery (University College London)
Garcia, Y. S. A. J. G. N. (2013) · CRC Press eBooks · doi:10.1201/b15421-3
Mechanistic Insight into Tau Fibril Cross-Seeding Barriers: Structural Order and Disorder
Weismiller, H. A. (2019) · Digital Commons - DU (University of Denver)
The Analysis of Exosomal Tau Release and its Regulation
Bradshaw, A. (2018) · UCL Discovery (University College London)
Ochoa, C. D., Balczon, R., & Stevens, T. (2013)
Doersch, A. (2020) · University of Minnesota Digital Conservancy (University of Minnesota)
Invertebrate and Vertebrate Models of Tauopathies
Götz, J., Ittner, L. M., Götz, N. N., Lam, H., & Nicholas, H. (2011) · Royal Society of Chemistry eBooks · doi:10.1039/bk9781849731843-00069
Baker, K., & Dalley, J. W. (2023) · Brain and Neuroscience Advances · doi:10.1177/23982128231199006
Chen, S., Chang, Y., Li, L., Acosta, D., Li, Y., Guo, Q., Wang, C., Turkes, E., Morrison, C. T., Julian, D. L., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22601026
Chen, S., Chang, Y., Li, L., Acosta, D. M., Li, Y., Guo, Q., Wang, C., Turkes, E., Morrison, C. T., Julian, D. L., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22601020
Metadata
- Authors
- de Calignon, A., Fox, L. M., Pitstick, R., Carlson, G. A., Bacskai, B. J., Spires-Jones, T. L., & Hyman, B. T.
- Affiliations
- Harvard University (US)
- McLaughlin Research Institute (US)
- Corresponding author
- Hyman, Bradley T.
- Venue
- Nature
- Published
- 2010-03-31
- Volume
- 464
- Issue
- 7292
- Pages
- 1201-1204
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3091360
- OpenAlex
- W2100026237
- Cited by
- 517
- References
- 31
- Citations by year
- 2026: 11 · 2025: 14 · 2024: 12 · 2023: 30 · 2022: 24 · 2021: 28 · 2020: 26 · 2019: 19 · 2018: 26 · 2017: 38 · 2016: 40 · 2015: 39 · 2014: 26 · 2013: 48 · 2012: 54
- FWCI
- 39.85
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- National Institute on Aging (AG-08487, R01AG026249, R01AG008487, AG026249, P50AG005134, K99AG033670, P30AG062421)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- caspase activation, neurofibrillary tangles, tau protein, Alzheimer's disease, frontotemporal dementia, tau transgenic mice, neuronal survival, neurodegeneration, tau truncation, APOE ε4, APOE3, APOE2, APOE genotype, multiphoton imaging, tau aggregation
- MeSH terms
- Animals, Brain, Enzyme Activation, Humans, Mice, Transgenic, Neurons, Protein Processing, Post-Translational, Solubility, Time Factors, Neurofibrillary Tangles, tau Proteins, Cell Death, Caspases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
